ukmla MCQ (SBA): Obesity pharmacotherapy in T2DM

Instant feedback + full explanation. One question, done properly.

MediumEndocrinologyObesity pharmacotherapy in T2DMukmlamrcgp aktpaneprescribing safety assessment

A 45-year-old woman with BMI 42 kg/m² and poorly controlled T2DM despite metformin is considering adjunct pharmacotherapy for weight loss. Which agent is appropriate?

Educational content. Not a substitute for clinical judgement or local policy.

ukmla MCQ: Obesity pharmacotherapy in T2DM — Answer & Explanation | ia